XAMS
HYDRA
Market cap335mUSD
Jul 22, Last price
226.00EUR
1D
-0.88%
1Q
5.61%
Jan 2017
410.16%
Name
Hydratec Industries NV
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Hydratec Industries N.V. is a global manufacturing entity, active through its various subsidiaries in producing and distributing specialized industrial systems and precision plastic components. Its extensive reach spans the Netherlands, the broader European continent, Asia, both North and South America, Africa, and Oceania. The company's diverse product portfolio addresses key sectors including food processing, healthcare, and mobility. Among its core offerings are advanced sterilized product handling systems and sophisticated automated packaging solutions, capable of handling sterilized foodstuffs in pouches, tins, and jars, as well as prepared salads and agricultural products in bags, nets, boxes, and crates. For the poultry industry, Hydratec supplies industrial incubators for day-old chicks, alongside automated systems for processing hatchery eggs and chicks. It also provides environmental control equipment for air and water treatment, specialized hatchery management software for process optimization, and comprehensive service and support for all hatchery operations. In the plastics sector, the firm manufactures extrusion machinery for PVC, PVC-O, and PO pipes. It also specializes in plastic injection molded parts utilized in climate control systems, commercial vehicles, bicycle components, and coffee machines. Furthermore, Hydratec produces intricate rubber and plastic precision components crucial for fuel systems, braking and drive mechanisms, dispensing systems for various liquids (such as beer, coffee, and milk), medical cartridges, point-of-care instruments, and other diagnostic equipment. Hydratec Industries N.V. is headquartered in Amersfoort, the Netherlands.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||